Aerken Maolake

554 total citations
16 papers, 407 citations indexed

About

Aerken Maolake is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Aerken Maolake has authored 16 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Aerken Maolake's work include Prostate Cancer Treatment and Research (7 papers), Chemokine receptors and signaling (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Aerken Maolake is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Chemokine receptors and signaling (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Aerken Maolake collaborates with scholars based in Japan, United States and Taiwan. Aerken Maolake's co-authors include Kouji Izumi, Atsushi Mizokami, Yoshifumi Kadono, Ariunbold Natsagdorj, Hiroaki Iwamoto, Kazuyoshi Shigehara, Wen‐Jye Lin, Suguru Kadomoto, Mikio Namiki and Kazuaki Machioka and has published in prestigious journals such as Cancer Research, Oncotarget and Cancer Science.

In The Last Decade

Aerken Maolake

16 papers receiving 402 citations

Peers

Aerken Maolake

ONCOL

PRM

IMMUN

Yuuki Ohara Japan

Haruhisa Kitano Japan

De Sen Wan China

Louqian Zhang China

Guangyu An China

Atsushi Mitsuhashi Japan

Yiying Wang China

Casilda Llácer Spain

Mohammad Farhad United States

Yuuki Ohara Japan

Aerken Maolake

172 ×0.8

ONCOL

117 ×0.7

PRM

105 ×0.7

IMMUN

133 ×1.3

67 ×0.9

Citations per year, relative to Aerken Maolake Aerken Maolake (= 1×) peers Yuuki Ohara

Countries citing papers authored by Aerken Maolake

Since Specialization

Citations

This map shows the geographic impact of Aerken Maolake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aerken Maolake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aerken Maolake more than expected).

Fields of papers citing papers by Aerken Maolake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aerken Maolake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aerken Maolake. The network helps show where Aerken Maolake may publish in the future.

Co-authorship network of co-authors of Aerken Maolake

This figure shows the co-authorship network connecting the top 25 collaborators of Aerken Maolake. A scholar is included among the top collaborators of Aerken Maolake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aerken Maolake. Aerken Maolake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lerman, Irina, Xiaoting Ma, Aerken Maolake, et al.. (2019). Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression. Molecular Cancer Research. 17(4). 845–859. 19 indexed citations

Makino, Tomoyuki, Kouji Izumi, Aerken Maolake, et al.. (2019). Abstract 1968: Tumor necrosis factor-α upregulation of CCR7 induces prostate cancer cell migration in lymphatic metastasis. Tumor Biology. 1968–1968. 1 indexed citations

Natsagdorj, Ariunbold, Kouji Izumi, Kazuaki Machioka, et al.. (2018). CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells. Cancer Science. 110(1). 279–288. 42 indexed citations

Maolake, Aerken, Kouji Izumi, Ariunbold Natsagdorj, et al.. (2018). Tumor necrosis factor‐α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation. Cancer Science. 109(5). 1524–1531. 73 indexed citations

Mizokami, Atsushi, Kazuaki Machioka, Kouji Izumi, et al.. (2017). Abstract 85: Establishment of cabazitaxel-resistant prostate cancer cell lines. Cancer Research. 77(13_Supplement). 85–85. 1 indexed citations

Izumi, Kouji, Aerken Maolake, Ariunbold Natsagdorj, et al.. (2017). C‐C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment. Cancer Science. 109(3). 724–731. 27 indexed citations

Izumi, Kouji, Aerken Maolake, Masashi Iijima, et al.. (2016). Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma. Anticancer Research. 36(9). 4961–4964. 9 indexed citations

Iwamoto, Hiroaki, Kouji Izumi, Ariunbold Natsagdorj, et al.. (2016). Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma. Anticancer Research. 36(10). 5557–5562. 13 indexed citations

Maolake, Aerken, Kouji Izumi, Kazuyoshi Shigehara, et al.. (2016). Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis. Oncotarget. 8(6). 9739–9751. 98 indexed citations

10.

Izumi, Kouji, Hiroko Ikeda, Aerken Maolake, et al.. (2015). The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels. The Prostate. 75(10). 1034–1042. 37 indexed citations

11.

Izumi, Kouji, Atsushi Mizokami, Hsiu‐Ping Lin, et al.. (2015). Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer. Oncotarget. 7(7). 8389–8398. 35 indexed citations

12.

Maolake, Aerken, Kouji Izumi, Rie Takahashi, et al.. (2015). Efficacy of tegafur-uracil in advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy.. PubMed. 35(3). 1603–6. 3 indexed citations

13.

Izumi, Kouji, et al.. (2014). Predictive factor and antihypertensive usage of tyrosine kinase inhibitor-induced hypertension in kidney cancer patients. Oncology Letters. 8(1). 305–308. 4 indexed citations

14.

Izumi, Kouji, Wen‐Jye Lin, Hiroshi Miyamoto, et al.. (2014). Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level. Journal of Cancer Research and Clinical Oncology. 140(8). 1413–1419. 32 indexed citations

15.

Izumi, Keisuke, et al.. (2014). Effects of bethanechol chloride and distigmine bromide on postvoiding residual volume in patients with underactive bladder.. PubMed. 66(4). 241–7. 7 indexed citations

16.

Izumi, Kouji, Yoshiko Takahashi, Rie Takahashi, et al.. (2013). Factors predictive of oncological outcome after nephroureterectomy: comparison between laparoscopic and open procedures.. PubMed. 33(12). 5501–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact